R-Biopharm presents SARS-CoV-2 rapid antigen test
Peter Schubert, Chief Science Officer of the diagnostics provider R-Biopharm attends a presentation of a rapid antigen test, to detect the SARS-CoV-2 antigen, at their laboratory in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski